National Right to Life is raising alarm over the new study from the Ethics and Public Policy Center revealing that the risks of the abortion pill, mifepristone, are far greater than what the abortion industry claims.
“Every time pro-lifers want to challenge safety claims made about the abortion pill mifepristone, abortion advocates and their loyal media allies like to quote the claim of the drug’s official label from the Food and Drug Administration (FDA) that clinical studies showed ‘Serious adverse reactions were reported in <0.5% of women,’” said Randall K. O’Bannon, Ph.D., director of Education and Research at National Right to Life. “New data taken from the field show figures are twenty-two times that.”
Read the press release from National Right to Life here.